HC Wainwright Lifts Earnings Estimates for PDS Biotechnology

PDS Biotechnology Corporation (NASDAQ:PDSB – Free Report) – Analysts at HC Wainwright raised their Q3 2025 earnings per share (EPS) estimates for shares of PDS Biotechnology in a note issued to investors on Wednesday, August 13th. HC Wainwright analyst J. Pantginis now expects that the company will post earnings of ($0.25) per share for the […]

Leave a Reply

Your email address will not be published.

Previous post Comparing TFI International (NYSE:TFII) and Grupo Aeroportuario del Centro Norte (NASDAQ:OMAB)
Next post What is Roth Capital’s Estimate for PLBY Group Q3 Earnings?